Bampidis Vasileios, Azimonti Giovanna, Bastos Maria de Lourdes, Christensen Henrik, Durjava Mojca, Kouba Maryline, López-Alonso Marta, Puente Secundino López, Marcon Francesca, Mayo Baltasar, Pechová Alena, Petkova Mariana, Ramos Fernando, Sanz Yolanda, Villa Roberto Edoardo, Woutersen Ruud, Brantom Paul, Chesson Andrew, Westendorf Johannes, Manini Paola, Pizzo Fabiola, Dusemund Birgit
EFSA J. 2023 Feb 24;21(2):e07869. doi: 10.2903/j.efsa.2023.7869. eCollection 2023 Feb.
Following a request from the European Commission, EFSA was asked to deliver a scientific opinion on the safety of a tincture derived from L. (gentian tincture). It is intended to be used as a sensory additive for all animal species. The product is a water/ethanol solution, with a dry matter content of approximately 4.3% and it contains on average 0.0836% polyphenols (of which 0.0463% are flavonoids and 0.0027% xanthones) and 0.0022% gentiopicroside. The additive is intended for use in complete feed or drinking water up to a maximum level of 50 mg tincture/kg for all animal species, except horses, for which the proposed use is 200 mg/kg in complete feed. In a previous assessment, due to the genotoxic potential identified in vitro for xanthones (gentisin and isogentisin) and gentiopicroside the Panel on Additives and Products or Substances used in Animal Feed (FEEDAP) could not conclude on the safety of the additive for long-living animals and on risks of genotoxicity and carcinogenicity for dermal exposure of unprotected users. The additive did not raise safety concern for short-living animals, consumers and the environment. The applicant has provided information in the form of literature to address the previously identified genotoxic activity of xanthones and gentiopicroside and the risk for the user. Considering that the literature identified provided no new evidence, the FEEDAP Panel reiterated that it is not in a position to conclude on the safety of the additive for long-living and reproductive animals. No conclusions could be drawn on the potential of the additive to be a dermal/eye irritant or a skin sensitiser. When handling the tincture, exposure of unprotected users to xanthones (gentisin and isogentisin) and gentiopicroside cannot be excluded. Therefore, to reduce the risk, the exposure of the users should be minimised.
应欧盟委员会的要求,欧洲食品安全局(EFSA)被要求就一种源自龙胆属植物的酊剂(龙胆酊)的安全性发表科学意见。它拟用作所有动物种类的感官添加剂。该产品是一种水/乙醇溶液,干物质含量约为4.3%,平均含有0.0836%的多酚(其中0.0463%为黄酮类化合物,0.0027%为氧杂蒽酮)和0.0022%的龙胆苦苷。该添加剂拟用于全价饲料或饮用水中,除马以外的所有动物种类的最大使用量为50毫克酊剂/千克,对于马,建议在全价饲料中的使用量为200毫克/千克。在先前的评估中,由于在体外鉴定出氧杂蒽酮(龙胆黄素和异龙胆黄素)和龙胆苦苷具有遗传毒性潜力,动物饲料添加剂及产品或物质专家委员会(FEEDAP)无法就该添加剂对长寿动物的安全性以及未受保护使用者皮肤接触的遗传毒性和致癌风险得出结论。该添加剂对短寿命动物、消费者和环境未引起安全担忧。申请人已以文献形式提供信息,以解决先前确定的氧杂蒽酮和龙胆苦苷的遗传毒性活性以及对使用者的风险问题。鉴于所提供的文献未提供新的证据,FEEDAP专家委员会重申,无法就该添加剂对长寿和繁殖动物的安全性得出结论。无法就该添加剂成为皮肤/眼睛刺激物或皮肤致敏剂的可能性得出结论。在处理酊剂时,不能排除未受保护的使用者接触氧杂蒽酮(龙胆黄素和异龙胆黄素)和龙胆苦苷的情况。因此,为降低风险,应尽量减少使用者的接触。